GCIA
GILD icon

Gabelli & Co Investment Advisers’s Gilead Sciences GILD Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$279K Hold
2,000
– – 0.04% 214
2025
Q4 		$245K Buy
+2,000
New +$243K 0.04% 203
2016
Q2 		– Sell
-3,000
Closed -$276K – 174
2016
Q1 		$276K Hold
3,000
– – 0.03% 136
2015
Q4 		$304K Buy
3,000
+500
+20% +$52K 0.04% 141
2015
Q3 		$245K Buy
+2,500
New +$278K 0.03% 145

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Gabelli & Co Investment Advisers's GILD Position: Q1 2026 in Review

Gabelli & Co Investment Advisers held its Gilead Sciences (GILD) position steady in Q1 2026 at 2,000 shares worth $279K. The position accounts for 0.04% of the portfolio, ranked #214.

Gabelli & Co Investment Advisers first reported a position in GILD in Q3 2015 and has held it in 5 quarters since. The position peaked at $304K in Q4 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Gabelli & Co Investment Advisers held 2,000 shares of Gilead Sciences worth $279K as of Q1 2026.
  • Gabelli & Co Investment Advisers left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.04% of Gabelli & Co Investment Advisers's portfolio in Q1 2026, its #214 holding.
  • Gabelli & Co Investment Advisers first reported a position in Gilead Sciences in Q3 2015 and has held it in 5 quarters since.
  • Gabelli & Co Investment Advisers's Gilead Sciences position peaked at $304K in Q4 2015.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.